Efficacy and Safety of Sirolimus to Vascular Anomalies
NCT03583307
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
126
Enrollment
OTHER
Sponsor class
Conditions
Vascular Anomaly
Interventions
DRUG:
Sirolimus
Sponsor
West China Hospital